Versus Systems Inc. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of February 2023 for Versus Systems Inc., a foreign private issuer headquartered in Vancouver, Canada. The report details the entry into a material definitive agreement regarding a registered direct offering of common shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The primary financial data relates to the capital raise:
- Gross Proceeds: $2,250,000 raised from the sale of 2,500,000 common shares.
- Offering Price: $0.90 per common share.
- Placement Agent Fee: 7% of aggregate proceeds paid in cash to Roth Capital Partners, LLC.
- Placement Agent Warrants: 175,000 warrants issued with an exercise price of $0.90 per share, exercisable for five years.
Material Changes
The material change reported is the completion of the registered direct offering on February 6, 2023. This transaction increased the company's share count by 2,500,000 common shares and provided gross proceeds of $2,250,000. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Use of Proceeds: The Company intends to use the net proceeds for working capital and general corporate purposes.
Lock-Up Period: The Company agreed not to issue or announce the issuance of any common shares or equivalents, nor file new registration statements (other than those related to this offering), for 45 calendar days following the closing date.
Risks: The filing notes that the descriptions of the agreements are qualified by reference to the full text of the exhibits. No specific operational risks or contingencies are detailed in this summary text.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 7% placement fee and other offering expenses.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.2) for specific covenants and exceptions to the lock-up period.
- Confirm the dilution impact of the 2,500,000 new shares and 175,000 placement agent warrants on existing shareholders.
- Check subsequent filings for the actual deployment of funds for working capital.